专题:Psoriasis: Treatment and Pathogenesis

This cluster of papers focuses on the reciprocal developmental pathways for the generation of pathogenic effector TH17 cells and regulatory T cells, particularly in the context of autoimmune inflammation, interleukin-23, psoriasis, and the role of cytokines such as TGF-ß. It also explores the differentiation, cytokine profile, and function of human interleukin 17–producing helper T cells.
最新文献
Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity

article Full Text OpenAlex

International Eczema Council Definitions of Low Disease Activity and Remission in Atopic Dermatitis

article Full Text OpenAlex

Glucocorticoid treatment in patients with inflammatory rheumatic diseases: current practice and open questions

article Full Text OpenAlex

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial

article Full Text OpenAlex

Distinctive DNA sequence features define epigenetic longevity of inflammatory memory

article Full Text OpenAlex

Subversion of kynurenine-induced AHR activation in CD8 T cells by kynureninase-expressing antigen-presenting cells

article Full Text OpenAlex

The Double-Edged Sword of Type 17 Immunity in Wound Healing and Skin Barrier Repair: Microenvironment-Driven Functional Plasticity

article Full Text OpenAlex

Vitamin D3 as an immunomodulatory agent: molecular mechanisms, clinical translation, and precision therapeutic strategies

article Full Text OpenAlex

The brain–gut–skin axis in inflammatory and disfiguring skin diseases: mechanistic insights, clinical correlations, and therapeutic strategies

article Full Text OpenAlex

Real-World Effectiveness and Safety of Abrocitinib in Patients with Atopic Dermatitis: A 16-Week Single-Center Retrospective Cohort Study Compared with Upadacitinib and Baricitinib

article Full Text OpenAlex

近5年高被引文献
IL-17 and IL-17-producing cells in protection versus pathology

article Full Text OpenAlex 988 FWCI60.4983

Advances in the pathogenesis of psoriasis: from keratinocyte perspective

article Full Text OpenAlex 637 FWCI39.2035

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021

article Full Text OpenAlex 610 FWCI81.4997

Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach

article Full Text OpenAlex 498 FWCI39.7558

The IL-17 family in diseases: from bench to bedside

article Full Text OpenAlex 432 FWCI38.6886

Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

article Full Text OpenAlex 408 FWCI58.8148

Signaling pathways and targeted therapies for psoriasis

article Full Text OpenAlex 397 FWCI35.5541

Strategies for targeting cytokines in inflammatory bowel disease

article Full Text OpenAlex 371 FWCI139.8027

Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial

article Full Text OpenAlex 361 FWCI22.574

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

article Full Text OpenAlex 360 FWCI114.1312